文献速递神经肿瘤

肿瘤体积与钙化作为术前区分II/III级弥漫性胶质瘤的指标

Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas.
PubMed 文献 · J Neurooncol · 2023-02-07

这项回顾性研究纳入206例成人初发幕上II/III级弥漫性胶质瘤患者,评估术前临床因素区分恶性级别的能力。结果显示,在少突胶质细胞瘤(IDH突变且1p/19q共缺失)中,III级患者钙化更常见(p=0.0034)且肿瘤体积更大(p<0.001);在IDH突变型星形细胞瘤中,III级患者术前肿瘤体积更大(p=0.0042);而在IDH野生型星形细胞瘤中,所评估的术前临床因素在II级与III级之间均无显著差异。

要点

  • 少突胶质细胞瘤(IDH突变且1p/19q共缺失)III级较II级钙化更常见(p=0.0034)。
  • 少突胶质细胞瘤III级较II级术前肿瘤体积更大(p<0.001)。
  • IDH突变型星形细胞瘤III级较II级术前肿瘤体积更大(p=0.0042)。

核心结论

  • 在成人疑似初发幕上II/III级弥漫性胶质瘤中,钙化 presence 和较大的术前肿瘤体积可能作为术前指标,用于区分少突胶质细胞瘤(IDH突变且1p/19q共缺失)的II级与III级;较大的术前肿瘤体积在IDH突变型星形细胞瘤中可能具有类似效用。

研究设计与样本

  • 回顾性研究,纳入206例成人初发幕上II/III级弥漫性胶质瘤患者(依据2016年世界卫生组织中枢神经系统肿瘤分类),其中男性136例、女性70例,中位年龄41岁。

主要发现

  • 在少突胶质细胞瘤(IDH突变且1p/19q共缺失)患者中,III级患者钙化显著更常见(p=0.0034),且术前肿瘤体积显著更大(p<0.001)。
  • 在IDH突变型星形细胞瘤患者中,III级患者术前肿瘤体积显著更大(p=0.0042)。
  • 在IDH野生型星形细胞瘤患者中,所评估的术前临床因素在II级与III级之间均无显著差异。

关键数值与推荐

  • 少突胶质细胞瘤(IDH突变且1p/19q共缺失)III级 vs II级:钙化更常见(p=0.0034),术前肿瘤体积更大(p<0.001)。
  • IDH突变型星形细胞瘤III级 vs II级:术前肿瘤体积更大(p=0.0042)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To retrospectively evaluate preoperative clinical factors for their ability to preoperatively differentiate malignancy grades in patients with incipient supratentorial grade II/III diffuse gliomas. METHODS: This retrospective study included 206 adult patients with incipient supratentorial grade II/III diffuse gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system. The cohort included 136 men and 70 women, with a median age of 41 years. Preoperative factors included age, sex, presence of calcifications on computed tomography scans, and preoperative tumor volume measured using preoperative magnetic resonance imaging. RESULTS: In patients with oligodendrogliomas (IDH-mutant and 1p/19q-codeleted), calcifications were significantly more frequent (p = 0.0034) and tumor volume was significantly larger (p < 0.001) in patients with grade III tumors than in those with grade II tumors. Moreover, in patients with IDH-mutant astrocytomas, preoperative tumor volume was significantly larger (p = 0.0042) in patients with grade III tumors than in those with grade II tumors. In contrast, none of the evaluated preoperative clinical factors were significantly different between the patients with grade II and III IDH-wildtype astrocytomas. CONCLUSION: In adult patients with suspicison incipient supratentorial grade II/III diffuse gliomas, presence of calcifications and larger preoperative tumor volume might be used as preoperative indices to differentiate between malignancy grades II and III in oligodendrogliomas (IDH-mutant and 1p/19q-codeleted) and larger preoperative tumor volume might have similar utility in IDH-mutant astrocytomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Fukuya Y, Tamura M, Nitta M, et al. Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas. J Neurooncol. 2023. PMID: 36749444. doi:10.1007/s11060-023-04244-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。